webinar register page

Webinar banner
The Roche/Genentech GENERATION HD2 Study of Tominersen
Roche and Genentech have launched the GENERATION HD2 study of the huntingtin-lowering drug tominersen. Join HDSA as Roche/Genentech representatives Lauren Boak, Lifecycle Leader in Neurosciences and Rare Diseases, and Dr. Peter McColgan, Clinical Science Leader, speak about the study and address community questions.

Feb 8, 2023 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading